JAZZ

Jazz Pharmaceuticals PLC

Price

$252.16

return (12m)

111.54%

p/e

16.26

p/bv

3.19

DIVIDEND YIELD

0.00%

JAZZ price

Jazz Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment JAZZ

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.52%

3 months

5.33%

1 year

111.54%

2 years

120.73%

5 years

88.88%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals JAZZ

Valuation

P/E

16.26

Sector -4.38

Industry -4.38

P/BV

3.19

Sector 2.02

Industry 2.02

P/Revenue (PSR)

3.32

Sector -4.40

Industry -4.40

EV/EBITDA

39.30

Sector -263.09

Industry -263.09

EV/EBIT

66.23

Sector -702.90

Industry -702.90

P/EBITDA

9.52

Sector -4.39

Industry -4.39

P/EBIT

17.02

Sector -4.73

Industry -4.73

P/Total Assets

1.38

Sector 1.49

Industry 1.49

P/Net Current Assets

-6.62

Sector -11.70

Industry -11.70

P/Working Capital

8.80

Sector -3.19

Industry -3.19

EPS

14.93

Sector -2.14

Industry -2.14

BVPS

76.22

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

88.42%

Sector 36.74%

Industry 36.74%

EBITDA Margin

34.60%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

20.53%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

22.09%

Sector -38.22%

Industry -38.22%

Net Profit Margins

20.45%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.11

Sector 0.03

Industry 0.03

Profitability

ROE

19.59%

Sector -65.14%

Industry -65.14%

ROA

8.49%

Sector -65.53%

Industry -65.53%

ROIC

14.27%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

1.78

Sector 2.90

Industry 2.90

Net Debt / EBITDA

2.72

Sector -6.07

Industry -6.07

Net Debt / EBIT

4.58

Sector -8.26

Industry -8.26

Net Debt / Equity

0.24

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.69

Sector -0.05

Industry -0.05

Equity/Assets

0.43

Sector 0.41

Industry 0.41

Liabilities/Assets

0.57

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

8.26%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF Jazz Pharmaceuticals ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$252.16

Fair Value

$160.01

Upside Return potential.

-36.54%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals JAZZ

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
JAZZ Jazz Pharmaceuticals PLC	$252.16	114.29%	0.00%	16.26	3.19	19.59%	20.45%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

JAZZ Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Jazz Pharmaceuticals

Jazz Pharmaceuticals PLC

Average Investor10 user rating

4.0 (2 people)

United States

23 years

Founded: 2003

2007

Time since IPO - 19 years

1.620

Employees

Jazz Pharmaceuticals PLC (United States) is listed on the Nasdaq and has a market capitalization of $15.30 billion, with shareholders equity totaling $4.80 billion.

The company employs approximately 1.620 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Jazz Pharmaceuticals PLC reported $4.60 billion in revenue, generating net income of $940.76 million.

Key financial metrics include a P/E ratio of 16.26, a price-to-book (P/B) ratio of 3.19, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker JAZZ.

Market cap

$15.30 billion

Net worth

$4.80 billion

$4,801,700,000.00

Assets

$11.08 billion

$11,080,900,000.00

Total Shares Outstanding

63.00 million

63,000,000

Average Daily Trading Volume

$836.00 Thousand

$835,999.04

Sector

Health Care

Industry

Biotechnology

JAZZ

JAZZ revenue and profits

Financial Results JAZZ

DRAG THE FRAME TO SEE MORE DATA

JAZZ cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Jazz Pharmaceuticals (JAZZ) today?

A cotação de Jazz Pharmaceuticals (JAZZ) hoje está em US$ 252.16, com uma variação de 111.54% em relação ao último ano. A cotação de Jazz Pharmaceuticals (JAZZ) iniciou o ano negociando na casa dos US$ 170.00 e hoje está em US$ 252.16. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Jazz Pharmaceuticals (JAZZ) e dados de ações do Ibovespa e mercados internacionais.

Quando Jazz Pharmaceuticals (JAZZ) paga dividendos?

Jazz Pharmaceuticals (JAZZ) não distribuiu dividendos no último ano.

Is Jazz Pharmaceuticals (JAZZ) a good investment?

Atualmente, Jazz Pharmaceuticals (JAZZ) está cotada a US$ 252.16, com um P/L de 16.26, representando um desvio de -514% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 111.54 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 111.54%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Jazz Pharmaceuticals (JAZZ) stock?

Investir em ações de Jazz Pharmaceuticals (JAZZ) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Jazz Pharmaceuticals (JAZZ) yield today?

A rentabilidade de Jazz Pharmaceuticals (JAZZ) foi de 0.52% no último mês, 111.54% no último ano e 88.88% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Jazz Pharmaceuticals (JAZZ) hoje, o investimento total seria de US$ 25,216.00, com base na cotação atual de US$ 252.16.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 53,341.93
Em 5 anos: US$ 47,627.98
Em 10 anos: US$ 25,216.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

JAZZ

Jazz Pharmaceuticals PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment JAZZ

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING JAZZ WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Jazz Pharmaceuticals

Jazz Pharmaceuticals PLC

United States

23 years

2007

1.620

PROFIT X PRICE JAZZ

Financial Results JAZZ

JAZZ cash flow

Asset, Revenue and Profit Growth - JAZZ

JAZZ balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions